NCT05819606 2025-09-22
PER2PSMA
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Completed
Clinical Trials
9 trialsNCT00004261 2018-02-22
EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma
University Health Network, Toronto
Phase 1 Terminated
NCT00466752 2017-11-22
Sorafenib Tosylate and Gene Expression Analysis in Patients Undergoing Surgery For High-Risk Localized Prostate Cancer
University of Washington
Phase 2 Completed
NCT00897351 2017-05-17
Study of Tissue and Blood Samples From Patients With Recurrent Prostate Cancer Who Received Lapatinib on Clinical Trial ECOG-E5803
Eastern Cooperative Oncology Group
Completed
NCT00459407 2014-10-08
Defined Green Tea Catechins in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostate
National Cancer Institute (NCI)
Phase 1 Completed
NCT00305669 2014-06-25
GM-CSF Before Surgery in Treating Patients With Localized Prostate Cancer
University of California, San Francisco
Phase 1 Completed
NCT01340599 2012-03-15
Defined Green Tea Catechin Extract in Treating Patients With Localized Prostate Cancer Undergoing Surgery
Case Comprehensive Cancer Center
Phase 2 Terminated
NCT00989105 2012-02-28
Technetium Tc 99m Demobesin-4 for Imaging Procedures in Patients With Prostate Cancer
Cancer Research UK
Phase 1 Terminated
NCT00176527 2009-12-11
Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
Rutgers, The State University of New Jersey
Phase 2 Terminated